Stroke:终末期肾病患者卒中死亡分析

2019-01-01 xing.T MedSci原创

由此可见,ESKD患者的卒中死亡率更高,女性和年轻人的差异最大。然而,死亡率随着时间的推移有所改善。

终末期肾病(ESKD)患者发生卒中的风险更高。近日,卒中领域权威杂志Stroke上发表了一篇研究文章,研究人员的目的是比较ESKD人群与一般人群之间卒中的死亡率。

研究人员将澳大利亚1980年至2013年期间以及新西兰1988年至2012年期间所有ESKD患者纳入分析。通过与国家死亡登记中心的数据联系确定了死亡的主要原因。研究人员根据年龄、性别和年份制定了卒中死亡的标准化死亡率。

研究人员纳入了60823例ESKD患者,在381874人次每年的随访期间发生941例卒中死亡。与一般人群相比,ESKD患者的卒中死亡率增加超过3倍(标准化死亡率为3.4; 95%CI为3.2-3.6),在年轻人和女性中明显更高。最大的风险是脑出血(标准化死亡率为5.2; 95%CI为4.5-5.9)。ESKD患者卒中死亡率随着时间的推移逐渐下降,尽管在2013年仍然翻了一番(2013年标准化死亡率为2.1; 95%CI为1.5-2.9)。

由此可见,ESKD患者的卒中死亡率更高,女性和年轻人的差异最大。然而,死亡率随着时间的推移有所改善。

原始出处:

Nicole L. De La Mata.et al.Death From Stroke in End-Stage Kidney Disease A Population-Based Study Using Data Linkage.Stroke. 2018.https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.023644

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1693480, encodeId=ac441693480fb, content=<a href='/topic/show?id=7e2de81588c' target=_blank style='color:#2F92EE;'>#终末期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78158, encryptionId=7e2de81588c, topicName=终末期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f6429431807, createdName=anminleiryan, createdTime=Tue Jun 04 18:13:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025847, encodeId=a61c202584e62, content=<a href='/topic/show?id=a91d82583bf' target=_blank style='color:#2F92EE;'>#肾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82583, encryptionId=a91d82583bf, topicName=肾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Dec 16 17:13:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476372, encodeId=3d5914e63728d, content=<a href='/topic/show?id=eb69e81665d' target=_blank style='color:#2F92EE;'>#终末期肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78166, encryptionId=eb69e81665d, topicName=终末期肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb27278676, createdName=zengjiayao, createdTime=Thu Jan 03 06:13:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026253, encodeId=63a1102625378, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Jan 01 18:13:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1693480, encodeId=ac441693480fb, content=<a href='/topic/show?id=7e2de81588c' target=_blank style='color:#2F92EE;'>#终末期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78158, encryptionId=7e2de81588c, topicName=终末期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f6429431807, createdName=anminleiryan, createdTime=Tue Jun 04 18:13:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025847, encodeId=a61c202584e62, content=<a href='/topic/show?id=a91d82583bf' target=_blank style='color:#2F92EE;'>#肾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82583, encryptionId=a91d82583bf, topicName=肾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Dec 16 17:13:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476372, encodeId=3d5914e63728d, content=<a href='/topic/show?id=eb69e81665d' target=_blank style='color:#2F92EE;'>#终末期肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78166, encryptionId=eb69e81665d, topicName=终末期肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb27278676, createdName=zengjiayao, createdTime=Thu Jan 03 06:13:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026253, encodeId=63a1102625378, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Jan 01 18:13:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1693480, encodeId=ac441693480fb, content=<a href='/topic/show?id=7e2de81588c' target=_blank style='color:#2F92EE;'>#终末期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78158, encryptionId=7e2de81588c, topicName=终末期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f6429431807, createdName=anminleiryan, createdTime=Tue Jun 04 18:13:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025847, encodeId=a61c202584e62, content=<a href='/topic/show?id=a91d82583bf' target=_blank style='color:#2F92EE;'>#肾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82583, encryptionId=a91d82583bf, topicName=肾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Dec 16 17:13:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476372, encodeId=3d5914e63728d, content=<a href='/topic/show?id=eb69e81665d' target=_blank style='color:#2F92EE;'>#终末期肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78166, encryptionId=eb69e81665d, topicName=终末期肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb27278676, createdName=zengjiayao, createdTime=Thu Jan 03 06:13:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026253, encodeId=63a1102625378, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Jan 01 18:13:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1693480, encodeId=ac441693480fb, content=<a href='/topic/show?id=7e2de81588c' target=_blank style='color:#2F92EE;'>#终末期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78158, encryptionId=7e2de81588c, topicName=终末期)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f6429431807, createdName=anminleiryan, createdTime=Tue Jun 04 18:13:00 CST 2019, time=2019-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2025847, encodeId=a61c202584e62, content=<a href='/topic/show?id=a91d82583bf' target=_blank style='color:#2F92EE;'>#肾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82583, encryptionId=a91d82583bf, topicName=肾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=db5b227, createdName=gostraight, createdTime=Mon Dec 16 17:13:00 CST 2019, time=2019-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476372, encodeId=3d5914e63728d, content=<a href='/topic/show?id=eb69e81665d' target=_blank style='color:#2F92EE;'>#终末期肾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78166, encryptionId=eb69e81665d, topicName=终末期肾病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5fb27278676, createdName=zengjiayao, createdTime=Thu Jan 03 06:13:00 CST 2019, time=2019-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1026253, encodeId=63a1102625378, content=卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=健健, createdTime=Tue Jan 01 18:13:00 CST 2019, time=2019-01-01, status=1, ipAttribution=)]
    2019-01-01 健健

    卒中虽然是临床上常见病,溶栓,取栓等血管内治疗也很成熟,但是仍然有很多未知问题有待认知!

    0

相关资讯

终末期肾病患者如何选择透析方式?

近十多年来,无论是血液透析还是腹膜透析均在自身技术上有了突飞猛进的发展。随着研究的深入,越来越多的观察发现两种透析模式在是不同类型的终末期肾功能衰竭(ESRD)患者中疗效相差甚远。

Ann Rheum Dis:肉芽肿病伴多血管炎引起的终末期肾病患者肾移植后的生存率改善

肾移植与GPA导致的ESRD患者全因死亡率显著降低相关,这主要是由于CVD死亡风险降低。

NEJM:尿毒症霜-病例报道

尿毒症霜与严重的氮质血症有关,并且是由汗液蒸发后皮肤上尿素结晶所致。在血液透析广泛可用的地区,这种症状十分罕见。

Arthritis Rheumatol:1995年至2014年狼疮性肾炎导致终末期肾病的死亡趋势

1995年至2014年间,白人、非洲裔美国人和西班牙裔患者的全因死亡率大幅下降,因心血管疾病和感染导致的死亡风险降低。

Diabetes Care:年轻1型糖尿病患者终末期肾病累积发病率降低

由此可见,在瑞典1型糖尿病患者人群中发生ESRD的风险仍然很低,而且似乎也随着时间的推移而有所降低。

Diabetic Med:性别调控亚洲2型糖尿病患者成纤维细胞生长因子21与终末期肾病的关联性

近日,国际杂志 《Diabetic Med》上在线发表一项关于性别调节亚洲2型糖尿病患者成纤维细胞生长因子21与终末期肾病的关联,该研究是一项为期6.3年的前瞻性队列研究。研究血浆成纤维细胞生长因子21是否能独立预测亚洲2型糖尿病患者终末期肾病的风险。 在这项前瞻性队列研究中,研究人员在新加坡的一家地区医院对1700名患有2型糖尿病的亚洲人进行了平均6.3年随访。通过与国家肾脏登记处的数据来